Selective killing of transformed cells in combination with inhibitors of polyamine biosynthesis and S-phase specific drugs.
D002455:Cell Division / Q000187:drug effects*; D002471:Cell Transformation, Neoplastic; D003561:Cytarabine / Q000494:pharmacology*; D004357:Drug Synergism; D000518:Eflornithine; D006367:HeLa Cells; D006801:Humans; D007399:Interphase / Q000187:drug effects; D009952:Ornithine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011073:Polyamines / Q000096:biosynthesis*; D013095:Spermidine / Q000096:biosynthesis; D013096:Spermine / Q000096:biosynthesis
D011073:Polyamines; D003561:Cytarabine; D013096:Spermine; D009952:Ornithine; D013095:Spermidine; D000518:Eflornithine